Summer 2027 Intern, Engineered Cell Therapy Discovery
Bristol Myers Squibb
Summary
We are seeking a motivated intern to join the Engineered Cell Therapy Discovery team and gain hands-on experience supporting the research of next-generation CAR T therapies for patients with cancer and other diseases.
Job description
Position Summary
We are seeking a motivated intern to join the Engineered Cell Therapy Discovery team and gain hands-on experience supporting the research of next-generation CAR T therapies for patients with cancer and other diseases.
Under close supervision, you will perform assigned laboratory work, learn core in vitro T cell and assay techniques, and contribute to ongoing research projects.
Key Responsibilities
- Perform assigned experiments using established procedures and proper controls, with close guidance from a scientist.
- Assist with generating, expanding, and cryopreserving engineered T cells.
- Operate laboratory instrumentation to support phenotypic and functional assays (e.g., flow cytometry, live-cell imaging, immunoassays).
- Analyze experimental data and present results clearly to the team.
- Ask questions, seek guidance, and work effectively with colleagues across the team and other labs.
- Maintain accurate and timely electronic notebook records.
Qualifications & Experience
- Currently enrolled in a degree program in biological sciences, immunology, bioengineering, or a related discipline.
- Preferred: prior laboratory coursework or research experience (e.g., cell culture, flow cytometry, molecular biology).
- Preferred: exposure to primary T cell culture or CAR T cells.
- All candidates must be legally authorized to work in the United States at the time of hire and for the duration of their employment. Please note that visa sponsorship, including for student or temporary work authorization programs, is not available for this role. Candidates must have work authorization that does not require sponsorship now or in the future.
Core Skills
- Basic knowledge of biological sciences, immunology, or a related discipline.
- Follows established procedures accurately, with strong organization and attention to detail in documenting experiments.
- Communicates effectively and works well as part of a team; asks questions and seeks guidance.
Requirements
- Currently enrolled in a degree program in biological sciences, immunology, bioengineering, or a related discipline
- Legally authorized to work in the United States at time of hire and for duration of employment
- Work authorization that does not require sponsorship now or in the future
- Basic knowledge of biological sciences, immunology, or a related discipline
- Follows established procedures accurately with strong organization and attention to detail
- Communicates effectively and works well as part of a team
- Preferred: prior laboratory coursework or research experience (e.g., cell culture, flow cytometry, molecular biology)
- Preferred: exposure to primary T cell culture or CAR T cells
Benefits
- Comprehensive benefits
- Limited intern benefits
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.